Titan Pharmaceuticals Inc (TTNP)
7.01
-0.31
(-4.23%)
USD |
NASDAQ |
Apr 22, 16:00
Titan Pharmaceuticals Shareholders Equity (Quarterly): 6.642M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 6.642M |
September 30, 2023 | 8.133M |
June 30, 2023 | -1.034M |
March 31, 2023 | -0.312M |
December 31, 2022 | 1.363M |
September 30, 2022 | 3.55M |
June 30, 2022 | 5.667M |
March 31, 2022 | 7.882M |
December 31, 2021 | 5.138M |
September 30, 2021 | 7.496M |
June 30, 2021 | 8.747M |
March 31, 2021 | 9.98M |
December 31, 2020 | 3.532M |
September 30, 2020 | -0.897M |
June 30, 2020 | 1.56M |
March 31, 2020 | 5.276M |
December 31, 2019 | 1.433M |
September 30, 2019 | -2.66M |
June 30, 2019 | -0.571M |
March 31, 2019 | 3.055M |
December 31, 2018 | 6.831M |
September 30, 2018 | 5.489M |
June 30, 2018 | -1.313M |
March 31, 2018 | -0.846M |
December 31, 2017 | 0.857M |
Date | Value |
---|---|
September 30, 2017 | 4.038M |
June 30, 2017 | 7.538M |
March 31, 2017 | 10.61M |
December 31, 2016 | 13.19M |
September 30, 2016 | 15.26M |
June 30, 2016 | 17.68M |
March 31, 2016 | 5.476M |
December 31, 2015 | 6.99M |
September 30, 2015 | 8.917M |
June 30, 2015 | 1.986M |
March 31, 2015 | 4.191M |
December 31, 2014 | 8.611M |
September 30, 2014 | 4.251M |
June 30, 2014 | 3.463M |
March 31, 2014 | 4.282M |
December 31, 2013 | 5.76M |
September 30, 2013 | 1.022M |
June 30, 2013 | 2.146M |
March 31, 2013 | -3.048M |
December 31, 2012 | -23.13M |
September 30, 2012 | -27.13M |
June 30, 2012 | -23.00M |
March 31, 2012 | -23.69M |
December 31, 2011 | -20.08M |
September 30, 2011 | -17.55M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-2.66M
Minimum
Sep 2019
9.98M
Maximum
Mar 2021
3.733M
Average
3.55M
Median
Sep 2022
Shareholders Equity (Quarterly) Benchmarks
Outset Medical Inc | 122.89M |
Allurion Technologies Inc | -70.49M |
AIM ImmunoTech Inc | 10.23M |
Protalix BioTherapeutics Inc | 33.57M |
Armata Pharmaceuticals Inc | -32.06M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 8.086M |
Total Liabilities (Quarterly) | 1.444M |